CD8+ Tumour-Infiltrating Lymphocytes and Tumour Microenvironment Immune Types as Biomarkers for Immunotherapy in Sinonasal Intestinal-Type Adenocarcinoma. The gene discussed is CD8A; the disease is gastric intestinal type adenocarcinoma.